Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-18T12:12:04.527Z Has data issue: false hasContentIssue false
  • English
  • Français

The use of new antipsychotics

Published online by Cambridge University Press:  02 January 2018

S. Shah  and
F. Oyebode
S. Shah
Affiliation:
The Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham B15 2QZ
F. Oyebode
Affiliation:
The Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham B15 2QZ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
Psychiatric Bulletin , Volume 20 , Issue 8 , August 1996 , pp. 500
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1996

References

Kane, J., Honigfeld, G., Singer, J., et al (Clozaril Collaborative Study Group) (1988) Clozapine for the treatment resistant schizophrenic: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.